At a glance
ClinicalIndex Comparison RecordN/ACompleted· 62 enrolled
Drug / intervention
Urgotul +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Non-inferiority of TulleGras M.S.® Versus Urgotul® in Pain Associated With Removal of Wound Dressing During Care of Venous Leg Ulcer. An Open-label, Multicenter, Randomized, Controlled, Crossover Study With Blinded Reading of Healing Criteria.
In Brief
A clinical study evaluating Urgotul and TulleGras M.S. for Venous Leg Ulcer. Completed, enrolled 62 participants across 27 sites.
Detailed Summary
Evaluation of the non-inferiority of TulleGras M.S.® versus Urgotul® in pain associated with removal of wound dressing during care of venous leg ulcer
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVenous Leg Ulcer
CountriesFrance
CollaboratorsCEN Biotech
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2014
First PostedApr 2014
Primary CompletionMar 2016
TodayJul 2026
First PostedApr 4, 2014
Enrollment StartFeb 1, 2014
Primary CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 12.2 years ago
Interventions
Urgotuldevice
sterile, hydrocolloid dressing, that consist of a polyester fabric coated with hydrocolloid particles and vaseline
TulleGras M.S.device
Sterile dressing that consists of viscose tissue coated with mineral vaseline